Lumbar spine disease
Conditions
Interventions
Sponsors
Fuyang People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. ASA Level I-II; 2. Age range: 18-75 years old; 3. BMI 18-30 kg/m^2 ; 4. After fully explaining the content of the clinical trial, patients and their families voluntarily joined and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Preoperative Mini Mental State Examination (MMSE) score <= 25 points; 2. History of neurological disorders, mental illnesses, and cardiovascular diseases; 3. History of allergy to local anesthetics; 4. Have a history of dependence on painkillers and drug use; 5. Patients with infection at the puncture site and abnormal coagulation function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total postoperative sufentanil dosage; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse reaction;Time of first use of analgesics after surgery;VAS pain scores during rest and turning after surgery;PCIA effective compression frequency, dose of additional flurbiprofen axetil;Postoperative recovery quality;Postoperative incidence of chronic pain; | — |
Countries
China
Contacts
Public ContactMa Xingjun
Fuyang People's Hospital
Outcome results
None listed